Medical Research Council

Jun 182012
 

Following the previous announcement of a Biomedical Catalyst Fund, the Medical Research Council and the Technology Strategy Board have launched the scheme. The programme acknowledges that healthcare models are facing great challenges and that companies and academics must work together to develop innovative solutions. Support is available for projects arising from any sector or discipline that are aimed at addressing healthcare challenges.

Read more ...
Dec 062011
 

Stratified medicine is a priority area for the Medical Research Council (MRC), which will commit £60m to this area over the next four years. MRC has now invited researchers to submit outline proposals for funding for the development of disease-focussed consortia to stratify disease. Up to £60m is available over 4 years.

Read more ...
Dec 062011
 

As part of a package of measures to drive growth in the UK’s life sciences sector, the Prime Minister has announced a three year £180 million programme to support some of the UK’s leading life science companies and academia, enabling them to move more quickly from discovery to commercialisation.

Read more ...
Dec 062011
 

The Medical Research Council (MRC) has announced that its ‘Experimental Medicine Challenge Grants’, focusing on ‘Studies of Disease Mechanisms in Humans’ will be launched in early 2012. Projects should address substantial, important medical questions. The anticipated funding range is £2-4m per 5 year award.

Read more ...
Oct 182010
 

The Developmental Pathway Funding Scheme (DPFS) is a new, rigorously-assessed, funding scheme set up by the Medical Research Council (MRC) to help strengthen the translation of fundamental research towards patient benefit. It does not fund discoveries of new causes or risk factors of disease, biomarkers, drug targets, biomaterials or research tools, but takes these as starting

Read more ...